Montair Chewable 5 mg
Product Class: Leukotriene Receptor Antagonist (Anti-Allergic / Anti-Asthma Agent)
Active Substance: Montelukast Sodium
Concentration: 5 mg per chewable tablet
Price For: 30 chewable tablets
Brand: Montair Chewable (Cipla)
Product Overview
Montair Chewable 5 mg contains montelukast sodium, a leukotriene receptor antagonist designed for the management of asthma and allergic conditions. This chewable formulation is especially suitable for children and individuals who prefer not to swallow tablets.
It provides effective long-term control of asthma symptoms and relief from allergic rhinitis.
Drug Class
Montair Chewable belongs to the leukotriene receptor antagonists (LTRAs), used for asthma prevention and allergy management.
Indications
Primary Uses
- Asthma maintenance therapy in children
- Allergic rhinitis (seasonal and perennial)
- Prevention of exercise-induced bronchospasm
Secondary Uses
- Reduction of airway inflammation
- Adjunct therapy in asthma management
Mechanism of Action
Montelukast works by blocking leukotriene receptors (CysLT1):
- Reduces inflammation in the airways
- Prevents bronchoconstriction
- Decreases mucus production
- Improves breathing and symptom control
This targeted mechanism helps manage both asthma and allergic symptoms effectively.
Dosage & Administration
- Typical dose: 5 mg once daily
The tablet should be chewed completely before swallowing, usually taken in the evening.
Use in Females
Montair Chewable is used in both children and adults, including females. It should be used with caution during pregnancy under medical advice.
Pre-Treatment Assessment
- Evaluation of asthma or allergy severity
- Review of current medications
- Assessment of liver function if needed
Effectiveness
Montair Chewable is effective in controlling asthma symptoms and reducing allergic reactions, especially when used consistently.
Risk Management
Common Side Effects
- Headache
- Abdominal discomfort
- Cough
Less Common Effects
- Dizziness
- Fatigue
- Behavioral changes (rare)
Serious Side Effects
- Neuropsychiatric effects (rare)
- Allergic reactions
Mitigation Strategies
- Ensure consistent daily use
- Monitor for mood or behavior changes
- Consult a doctor if adverse effects occur
What to Avoid While Taking Montair Chewable
- Skipping doses
- Using as an emergency asthma treatment
- Combining with similar medications without advice
Drug Interactions
- Minimal significant interactions
- Caution with drugs affecting liver metabolism
Sourcing & Selection
When selecting Montair Chewable, ensure:
- Trusted manufacturer (Cipla)
- Correct pediatric dosage (5 mg)
- Authentic packaging
Conclusion
Montair Chewable 5 mg is a convenient and effective option for managing asthma and allergies, particularly in children. Its chewable form and once-daily dosing make it easy to use while providing reliable symptom control.
It is used for asthma control and allergy relief, especially in children.
Chew completely before swallowing, once daily in the evening.
It starts working within hours, but full benefits take a few days.
It can be used long-term under medical supervision.